European pharma group Mundipharma has struck a deal with Janssen for two primary care diabetes drugs, Invokana and Vokanamet, in selected European countries.
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
